Literature DB >> 11958799

Prospective evaluation of the quality of oral anticoagulation management in an outpatient clinic and in general practices.

Tomas Holm1, Susanna Deutch, Jens F Lassen, Birthe Jastrup, Steen E Husted, Lene Heickendorff.   

Abstract

OBJECTIVE: To compare the quality of oral anticoagulant therapy (QOAT), before and after referral of patients on oral anticoagulant therapy (OAT) from a hospital outpatient clinic (HOC) to general practitioners (GPs).
DESIGN: Prospective observational study. Patients were identified by using the Laboratory Information System (LIS), containing all prescribed International Normalised Ratio of Prothrombin Time (INR) tests, from the HOC and GPs in the hospital submission area.
SETTING: The HOC in a rural hospital, Aarhus County, Denmark (55,000 inhabitants), and GPs in the submission area.
SUBJECTS: 124 OAT patients (59.7% males. Median age 70.0: 25-75 percentile: 62.0-76.0). MAIN OUTCOME MEASURE: The QOAT in terms of time spent within therapeutic INR interval (TI). The QOAT was compared 8 months before with 8 months after altering the monitoring organization. For patients monitored less than 8 months before the alteration, the QOAT was compared to a corresponding time period after the alteration.
RESULTS: We identified 124 OAT patients, and found a significant increase in the QOAT from 65.0% before to 69.1% after referral of the patients to the GPs (P<.0001). In 75 patients with full follow-up, the QOAT increased from 67.5% before to 69.7% after the alteration (P<.0001).
CONCLUSION: The results indicate that the QOAT in this geographical area is adequate, and that the quality performed by the GPs was at least as good as in the HOC. In order to document and increase the QOAT, continuous quality surveillance using the LIS has been initiated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11958799     DOI: 10.1016/s0049-3848(01)00401-7

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Administration of tramadol or ibuprofen increases the INR level in patients on warfarin.

Authors:  Jacob Juel; Torben Brøchner Pedersen; Christian Sigvald Langfrits; Svend Eggert Jensen
Journal:  Eur J Clin Pharmacol       Date:  2012-06-17       Impact factor: 2.953

2.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Authors:  Daniel M Witt; Robby Nieuwlaat; Nathan P Clark; Jack Ansell; Anne Holbrook; Jane Skov; Nadine Shehab; Juliet Mock; Tarra Myers; Francesco Dentali; Mark A Crowther; Arnav Agarwal; Meha Bhatt; Rasha Khatib; John J Riva; Yuan Zhang; Gordon Guyatt
Journal:  Blood Adv       Date:  2018-11-27

Review 3.  The case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit-risk ratio.

Authors:  Apostolos Safouris; Nikos Triantafyllou; John Parissis; Georgios Tsivgoulis
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570

4.  Security and cost comparison of INR self-testing and conventional hospital INR testing in patients with mechanical heart valve replacement.

Authors:  Qiu-lin Chen; Li Dong; Yi-jun Dong; Shu-lin Zhao; Bo Fu; Yu-qing Wang; Hong Jiang
Journal:  J Cardiothorac Surg       Date:  2015-01-16       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.